Here's a look at some of the top Wall Street stories for medical device companies this week: Boston Scientific's gain is St. Jude Medical's loss; Abiomed soars to new all-time high on FDA nod; Philips mulls 2016 IPO for lighting biz as bidding war heats up; SteadyMed prices $40m IPO well under range; Becton Dickinson to shed assets after CareFusion buy
CRM: Boston Scientific's gain is St. Jude Medical's loss
March 20, 2015 by Brad Perriello
Actavis, Bain Capital, Becton Dickinson & Co., Boston Scientific, CareFusion Corp., CVC Capital Partners, Food & Drug Administration (FDA), GSR Ventures, Kohlberg Kravis Roberts & Co. L.P., Lattice Power, Royal Philips, St. Jude Medical, SteadyMed Therapeutics, Temasek, Abiomed Inc., Allergan Inc.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1E4sij6
Cap comentari:
Publica un comentari a l'entrada